Difference between revisions of "Team:Tianjin/Demonstrate"

Line 435: Line 435:
 
         <p>This vector consists of three parts, an estrogen-inducible PCLB2 promoter <a href="http://parts.igem.org/Part:BBa_K2407002">(BBa_K2407002)</a>, the Cre-EBD sequence <a href="http://parts.igem.org/Part:BBa_K2407005">(BBa_K2407005)</a> and a CYC1 terminator<a href="http://parts.igem.org/Part:BBa_K2407003">(BBa_K2407003)</a>. We used overlap PCR to ligate these three parts and then the plasmids with URA3 and HIS nutritional label respectively through enzymatic digestion and ligation. Then this composite part <a href="http://parts.igem.org/Part:BBa_K2407011">(BBa_K2407011)</a>,was sequenced and proved to be accurate by using the promoter's forward primer and the terminator's reverse primer. The electrophoresis results below also showcased that the sequence length (about 2800bp) was correct.</p>
 
         <p>This vector consists of three parts, an estrogen-inducible PCLB2 promoter <a href="http://parts.igem.org/Part:BBa_K2407002">(BBa_K2407002)</a>, the Cre-EBD sequence <a href="http://parts.igem.org/Part:BBa_K2407005">(BBa_K2407005)</a> and a CYC1 terminator<a href="http://parts.igem.org/Part:BBa_K2407003">(BBa_K2407003)</a>. We used overlap PCR to ligate these three parts and then the plasmids with URA3 and HIS nutritional label respectively through enzymatic digestion and ligation. Then this composite part <a href="http://parts.igem.org/Part:BBa_K2407011">(BBa_K2407011)</a>,was sequenced and proved to be accurate by using the promoter's forward primer and the terminator's reverse primer. The electrophoresis results below also showcased that the sequence length (about 2800bp) was correct.</p>
 
           <div class="zxx_zoom_demo" align="center">
 
           <div class="zxx_zoom_demo" align="center">
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom2?action=raw&ctype=text/javascript"></script>
+
<script  type="text/javascript" src="https://2017.igem.org/Team:Tianjin/Resources/JS:zoom?action=raw&ctype=text/javascript"></script>
 
                     <div class="small_pic_demo" align="center">
 
                     <div class="small_pic_demo" align="center">
                      <a href="#pic_seven">
+
                   
                           <img src="https://static.igem.org/mediawiki/2017/8/84/Zhili.jpeg"></a>
+
                           <img src="https://static.igem.org/mediawiki/2017/8/84/Zhili.jpeg">
 
                     <p style="font-size:15px;text-align:center"><br/>Fig.3-1 This is a simplified version of this vector expressing the Cre recombinase enzyme. Cre-EBD is the coding sequence of Cre recombinase; PCLB2 is a constitutive  promoter in yeast; CYC1 is a terminator.</p>
 
                     <p style="font-size:15px;text-align:center"><br/>Fig.3-1 This is a simplified version of this vector expressing the Cre recombinase enzyme. Cre-EBD is the coding sequence of Cre recombinase; PCLB2 is a constitutive  promoter in yeast; CYC1 is a terminator.</p>
 
                     </div>
 
                     </div>
 +
                   
 
                     </div>
 
                     </div>
                    <div id="pic_seven" style="display:none;">
+
                 
                    <img src="https://static.igem.org/mediawiki/2017/8/84/Zhili.jpeg"><p style="font-size:15px;text-align:center"><br/>Fig.3-1 This is a simplified version of this vector expressing the Cre recombinase enzyme. Cre-EBD is the coding sequence of Cre recombinase; PCLB2 is a constitutive  promoter in yeast; CYC1 is a terminator.</p>
+
 
+
 
                    
 
                    
 
                    
 
                    

Revision as of 15:30, 27 October 2017

/* OVERRIDE IGEM SETTINGS */

Demonstrate